Terconazole Cream
NDC Package 51672-1302-0
Package Information
Terconazole cream is a medication used to treat vaginal yeast infections. This formulation utilizes a cream delivery system. Marketed by Sun Pharmaceutical Industries, Inc., this product is identified by NDC 51672-1302 and is authorized under FDA application ANDA075953.
Identification & Billing
- RxCUI: 313227 - terconazole 0.8 % Vaginal Cream
- RxCUI: 313227 - terconazole 8 MG/ML Vaginal Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51672 - Sun Pharmaceutical Industries, Inc.
- 51672-1302 - Terconazole
- 51672-1302-0 - 1 TUBE, WITH APPLICATOR in 1 CARTON / 20 g in 1 TUBE, WITH APPLICATOR
- 51672-1302 - Terconazole
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51672-1302-0 identifies a specific commercial package of 1 tube, with applicator in 1 carton / 20 g in 1 tube, with applicator of Terconazole, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. This cream is formulated for vaginal use and contains terconazole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sun Pharmaceutical Industries, Inc. on April 06, 2004. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat vaginal yeast infections. Terconazole reduces vaginal burning, itching, and discharge that may occur with this condition. This medication is an azole antifungal. It works by stopping the growth of yeast (fungus) that causes the infection.
How is this Sun Pharmaceutical Industries, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672130200. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 20 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.